Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Tandem Diabetes Care (TNDM) Non Operating Income (2016 - 2025)

Historic Non Operating Income for Tandem Diabetes Care (TNDM) over the last 13 years, with Q3 2025 value amounting to -$2.3 million.

  • Tandem Diabetes Care's Non Operating Income fell 16553.61% to -$2.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$8.8 million, marking a year-over-year decrease of 18459.03%. This contributed to the annual value of $7.3 million for FY2024, which is 4407.37% down from last year.
  • As of Q3 2025, Tandem Diabetes Care's Non Operating Income stood at -$2.3 million, which was down 16553.61% from -$5.9 million recorded in Q2 2025.
  • Tandem Diabetes Care's Non Operating Income's 5-year high stood at $4.2 million during Q1 2023, with a 5-year trough of -$5.9 million in Q2 2025.
  • In the last 5 years, Tandem Diabetes Care's Non Operating Income had a median value of $144000.0 in 2022 and averaged $214421.1.
  • As far as peak fluctuations go, Tandem Diabetes Care's Non Operating Income skyrocketed by 68776.37% in 2023, and later plummeted by 67342.39% in 2025.
  • Tandem Diabetes Care's Non Operating Income (Quarter) stood at -$1.6 million in 2021, then soared by 204.46% to $1.7 million in 2022, then soared by 125.36% to $3.8 million in 2023, then tumbled by 84.05% to $598000.0 in 2024, then tumbled by 481.27% to -$2.3 million in 2025.
  • Its last three reported values are -$2.3 million in Q3 2025, -$5.9 million for Q2 2025, and -$1.2 million during Q1 2025.